POSTER 2

Efficacy and Safety of Trifarotene Cream 50µg/g for the Treatment of Acne-Induced Post-Inflammatory Hyperpigmentation in Subjects with Fitzpatrick Skin Types I-VI: Results from a Phase IV Trial (LEAP)

Andrew Alexis, MD; Eduardo Weiss, MD; John C. Browning, MD; James Del Rosso, DO; Antonio Martorell, PhD; Sunil Dhawan, MD; Linda Stein Gold, MD; Vivian Laquer, MD; Rajeev Chavda, MD; JP York, PhD; Seth Forman, MD; Angela Moore, MD

< Previous Poster | Next Poster >

Poster 2